CEO/CSO of Medigene AG
With our expert speakers from across the pharmaceutical industry and academia explore the latest advances CAR T cell therapies, and the up-and-coming field of T Cell Receptor therapies. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.
“I liked the fact that the conference was really focused … allowing to learn and discuss specific subjects with experts in the field”
“Excellent opportunity to discuss topics in detail and to network”.
“The research sessions were very good and of high quality”
As part of the Research & Technology Series: Immuno-oncology you will have full access to 100+ presentations across five meetings and an exceptional interdisciplinary networking and learning experience.
The full speaker panel can be found here
This complete meeting programme creates a collaborative environment in which you can create enduring relationships across a range of disciplines
Find out more